Familial Aggregation of Psoriasis and Co-Aggregation of Autoimmune Diseases in Affected Families.
autoimmune diseases
familial aggregation
genetic epidemiology
psoriasis
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
18 Jan 2019
18 Jan 2019
Historique:
received:
01
01
2019
revised:
11
01
2019
accepted:
14
01
2019
entrez:
24
1
2019
pubmed:
24
1
2019
medline:
24
1
2019
Statut:
epublish
Résumé
Psoriasis is considered to result from the interaction of genetic factors and environmental exposure. The evidence for familial aggregation in psoriasis has been reported but population-based studies related to the magnitude of genetic contribution to psoriasis are rare. This study aimed to evaluate the relative risks of psoriasis in individuals with affected relatives and to calculate the proportion of genetic, shared, and non-shared environmental factors contributing to psoriasis. The study cohort included 69,828 patients diagnosed with psoriasis enrolled in National health Insurance in 2010. The adjusted relative risks (RR) for individuals with an affected first-degree relative and affected second-degree relative were 5.50 (95% CI (Confidence Interval), 5.19⁻5.82) and 2.54 (95% CI, 2.08⁻3.12) respectively. For those who have affected first-degree relatives, their RR was 1.45 (95% CI, 1.17⁻1.79) for Sjogren's syndrome and 1.94 (95% CI, 1.15⁻3.27) for systemic sclerosis. This nationwide study ascertains that family history of psoriasis is a risk factor for psoriasis. Individuals with relatives affected by psoriasis have higher risks of developing some autoimmune diseases.
Identifiants
pubmed: 30669308
pii: jcm8010115
doi: 10.3390/jcm8010115
pmc: PMC6352137
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Ministry of Science and Technology, Taiwan
ID : 105-2314-B-182A-069
Organisme : Chang Gung Memorial Hospital, Linkou
ID : 105-2314-B-182A-069-CMRPG3F0832
Références
Arch Dermatol. 1999 Dec;135(12):1479-84
pubmed: 10606053
Nat Rev Immunol. 2004 Mar;4(3):211-22
pubmed: 15039758
N Engl J Med. 2005 May 5;352(18):1899-912
pubmed: 15872205
J Eur Acad Dermatol Venereol. 2007 Nov;21(10):1337-43
pubmed: 17958839
Mult Scler. 2008 Jul;14(6):823-9
pubmed: 18573841
Acta Derm Venereol. 2009;89(3):262-6
pubmed: 19479122
Nature. 2009 Oct 8;461(7265):747-53
pubmed: 19812666
Eur J Hum Genet. 2010 Sep;18(9):1039-43
pubmed: 19826454
PLoS Genet. 2011 Aug;7(8):e1002254
pubmed: 21852963
Immunity. 2011 Dec 23;35(6):857-69
pubmed: 22195743
Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1193-8
pubmed: 22223662
Am J Hum Genet. 1990 Feb;46(2):222-8
pubmed: 2301392
Nat Genet. 2012 Dec;44(12):1341-8
pubmed: 23143594
Br J Dermatol. 2013 Aug;169(2):412-6
pubmed: 23574549
Ann Rheum Dis. 2015 Feb;74(2):369-74
pubmed: 24265412
J Am Acad Dermatol. 2014 Mar;70(3):512-6
pubmed: 24388724
Annu Rev Immunol. 2014;32:227-55
pubmed: 24655295
Clin Exp Dermatol. 2014 Oct;39(7):801-5
pubmed: 25156221
Curr Opin Rheumatol. 2015 Jan;27(1):91-8
pubmed: 25415529
BMJ Open. 2015 Jan 14;5(1):e006450
pubmed: 25588781
Arthritis Rheumatol. 2015 Jul;67(7):1904-12
pubmed: 25940005
JAMA Intern Med. 2015 Sep;175(9):1518-26
pubmed: 26193127
J Invest Dermatol. 2017 Mar;137(3):550-556
pubmed: 28063651
J Am Acad Dermatol. 1985 Sep;13(3):450-6
pubmed: 4056119
Ann Hum Genet. 1979 Jan;42(3):371-90
pubmed: 434779
Ann Hum Genet. 1972 Nov;36(2):163-84
pubmed: 4676360
Arch Dermatol. 1974 Feb;109(2):207-11
pubmed: 4814926
Arch Dermatol. 1978 Jun;114(6):874-8
pubmed: 566529
Ann Hum Genet. 1967 Aug;31(1):1-20
pubmed: 6056557
Acta Derm Venereol. 1982;62(3):229-36
pubmed: 6179364
Stat Med. 1994 Nov 15;13(21):2233-47
pubmed: 7846422
Arch Dermatol. 1994 Feb;130(2):216-24
pubmed: 8304761
J Am Acad Dermatol. 1993 Sep;29(3):428-34
pubmed: 8349859
Br J Ind Med. 1993 Sep;50(9):861-2
pubmed: 8398881